September 6, 2016 08:22 AM EDT
R&D

Al­ler­gan CEO Brent Saun­ders takes a pric­ing pledge: Preda­to­ry prac­tices must end

John Carroll

Editor & Founder

Caught in the lat­est tem­pest over dra­mat­ic price hikes for old ther­a­peu­tics, Al­ler­gan CEO Brent Saun­ders is swear­ing off the prac­tice, vow­ing to

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump taps Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, sur­geon gen­er­al picks

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

From vac­cines to psy­che­delics, five drug­mak­ers on what could change un­der a Trump ad­min­is­tra­tion

Sanofi in­tro­duces new 340B pay­ment mod­el — re­port

A service from the Financial Times